SCHEMBL26167

SCHEMBL26167

O=c1[nH]ccc(=S)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiouracil SCHEMBL18815516 0.85 TP53 (0.76) —
Pyrrolidine SCHEMBL2452735 0.85 MMP2 (0.72) —
Uracil SCHEMBL5089507 0.74 — —
Uracil SCHEMBL8235 0.74 — —
Uracil SCHEMBL3798527 0.74 CRBN (1.00) —
Uracil SCHEMBL11607890 0.74 — —
Uracil SCHEMBL28120281 0.74 TP53 (0.83) —
Uracil SCHEMBL16116311 0.72 — —
Uracil SCHEMBL710130 0.72 — —
Uracil SCHEMBL8767625 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 45754 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630827-B2 Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies ROGCON, INC. (US) 2026-05-19 — — US claimed
CN-122029177-A Oligonucleotides containing multiple ligands and/or lipids 阿达尔克斯制药有限公司 2026-05-12 — — CN claimed
CN-122028913-A Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions 阿达尔克斯制药有限公司 2026-05-12 — — CN claimed
CN-122029176-A Containing a plurality of oligonucleotides modified oligonucleotides 阿达尔克斯制药有限公司 2026-05-12 — — CN claimed
US-20260109977-A1 MODIFIED RNA FOR INCREASING PROTEIN EXPRESSION TRILINK BIOTECHNOLOGIES, LLC (US) 2026-04-23 — — US claimed
US-20260103824-A1 Compositions and Methods for Selectively Synthesizing Triple-indexed cDNA Libraries UNIV ROCKEFELLER (US) 2026-04-16 — — US claimed
US-12577554-B2 Methods for purification of messenger RNA TRANSLATE BIO, INC. (US) 2026-03-17 — — US claimed
US-12569572-B2 Messenger RNA therapy for the treatment of Friedreich's ataxia TRANSLATE BIO, INC. (US) 2026-03-10 — — US claimed
US-12552858-B2 Methods and compositions for delivering mRNA coded antibodies TRANSLATE BIO, INC. (US) 2026-02-17 — — US claimed
EP-4676446-A1 NOVEL LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS CureVac SE (DE) 2026-01-14 — — EP claimed
EP-0618925-A1 GAPPED 2' MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 1994-10-12 — — EP claimed
WO-1993013121-A1 GAPPED 2' MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 1993-07-08 — — WO claimed
EP-0506935-A1 NOVEL RIBONUCLEOSIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND DRUGS CONTAINING SAID COMPOUNDS PASTEUR MERIEUX SERUMS ET VACCINS, Société Anonyme : (FR) 1992-10-07 — — EP claimed
EP-0406309-A4 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES — 1992-08-19 — — EP claimed
US-5126439-A Complementary purines and pyrimidines TEMPLE UNIVERSITY (US) 1992-06-30 — — US claimed
WO-1992006993-A1 NOVEL RIBONUCLEOSIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND DRUGS CONTAINING SAID COMPOUNDS PASTEUR MERIEUX SERUMS ET VACCINS (FR) 1992-04-30 — — WO claimed
EP-0406309-A1 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES THE UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1991-01-09 — — EP claimed
WO-1989009221-A1 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1989-10-05 — — WO claimed
US-4604167-A Silver plating solution and silver plating process and pretreatment solution therefor SHINKO ELECTRIC INDUSTRIES CO., LTD. (JP) 1986-08-05 — — US claimed
US-4010075-A FERMENTATION OF STREPTOMYCES THE UPJOHN COMPANY (US) 1977-03-01 — — US claimed
Send feedback